BLUEJAY DIAGNOSTICS INC (BJDX)

US0956333019 - Common Stock

4.97  -0.76 (-13.26%)

BLUEJAY DIAGNOSTICS INC

NASDAQ:BJDX (9/27/2023, 10:25:47 AM)

4.97

-0.76 (-13.26%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-14 2023-08-14/amc
Earnings (Next)N/A N/A
Ins Owners325%
Inst Owners14.42%
Market Cap6.16M
Shares1.24M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts43.33
IPO11-10 2021-11-10
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

BJDX Daily chart

Company Profile

Bluejay Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Acton, Massachusetts and currently employs 16 full-time employees. The company went IPO on 2021-11-10. Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a near-patient testing system for triage and monitoring of disease progression. The firm's Symphony platform is a technology platform that provides measurements of key diagnostic biomarkers found in whole blood. The Symphony analyzer orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The firm's first product candidate, an IL-6 test for sepsis triage, is designed to provide results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and better triage/treatment decisions. The Symphony platform and its initial biomarker test, Symphony IL-6 test, is suited to address a subset of the global in vitro diagnostics devices (IVDs) market, including sepsis, cardio-metabolic diseases, cancer, and other diseases that require rapid tests.

Company Info

BLUEJAY DIAGNOSTICS INC

360 Massachusetts Avenue, Suite 203

Acton MASSACHUSETTS

P: 19786310152.0

Employees: 16

Website: https://bluejaydx.com/

BJDX News

News Image7 days ago - ChartmillKeep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

News Image7 days ago - ChartmillThese stocks are moving in today's session

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

News Image7 days ago - ChartmillWhich stocks are gapping on Wednesday?

Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

News Imagea month ago - Seeking AlphaBluejay Diagnostics to raise $1.59M to fund FDA approval process (NASDAQ:BJDX)

Medical technology company Bluejay Diagnostics (BJDX) Friday said it entered into a deal for the purchase and sale of 216,000 of its shares for $7.365 per share.In addition, in...

News Imagea month ago - Bluejay Diagnostics, Inc.Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

ACTON, Mass., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...

News Imagea month ago - Bluejay Diagnostics, Inc.Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

ACTON, Mass., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical technology company...

BJDX Twits

Here you can normally see the latest stock twits on BJDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example